Skip to main content

Bank of New York Mellon Corp

Bank

Position in ABUS — Arbutus Biopharma Corp

CIK 1390777 NEW YORK, NY

Position in ABUS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,179,751
+$472,573 QoQ
Shares Held
454,115
+19.7% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 175 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in ABUS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ABUS ranks #143 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABUS

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,179,751 454,115
2026-03-31 $1,707,178 379,373
2025-12-31 $1,865,865 387,914
2025-09-30 $1,812,131 399,148
2025-06-30 $1,132,027 366,352
2025-03-31 $1,217,300 348,797
2024-12-31 $1,155,531 353,374
2024-09-30 $1,357,397 352,571
2024-06-30 $1,525,622 493,729
2024-03-31 $1,051,671 407,625
2023-12-31 $1,142,069 456,828
2023-09-30 $916,477 451,467
2023-06-30 $1,036,419 450,617
2023-03-31 $1,280,723 422,681
2022-12-31 $975,167 418,527
2022-09-30 $736,229 385,461
2022-06-30 $961,639 354,849
2022-03-31 $1,094,222 367,189
2021-12-31 $1,372,986 352,953
2021-09-30 $1,102,190 256,921
2021-06-30 $727,174 239,992
2021-03-31 $171,215 51,416
2020-12-31 $199,914 56,314
2020-09-30 $55,516 17,737